These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 27219817

  • 1. Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.
    Vilozni D, Lavie M, Ofek M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Segel MJ, Efrati O.
    Ann Am Thorac Soc; 2016 Jun; 13(6):825-32. PubMed ID: 27219817
    [Abstract] [Full Text] [Related]

  • 2. The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.
    Vilozni D, Dagan A, Lavie M, Sarouk I, Bar-Aluma BE, Ashkenazi M, Mendelovich SL, Betzalel Y, Efrati O.
    Respir Care; 2018 Aug; 63(8):981-987. PubMed ID: 30018173
    [Abstract] [Full Text] [Related]

  • 3. The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.
    Sokol G, Vilozni D, Hakimi R, Lavie M, Sarouk I, Bat-El Bar, Dagan A, Ofek M, Efrati O.
    Respir Care; 2015 Dec; 60(12):1819-25. PubMed ID: 26374905
    [Abstract] [Full Text] [Related]

  • 4. Subjective and Objective Assessments of Flow-Volume Curve Configuration in Children and Young Adults.
    Weiner DJ, Forno E, Sullivan L, Weiner GA, Kurland G.
    Ann Am Thorac Soc; 2016 Jul; 13(7):1089-95. PubMed ID: 27070374
    [Abstract] [Full Text] [Related]

  • 5. Is an FEV1 of 80% predicted a normal spirometry in cystic fibrosis children and adults?
    König P, Ner Z, Acton JD, Ge B, Hewett J.
    Clin Respir J; 2018 Aug; 12(8):2397-2403. PubMed ID: 29920961
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis?
    Holland AE, Denehy L, Wilson JW.
    Eur Respir J; 2006 Jul; 28(1):96-101. PubMed ID: 16540499
    [Abstract] [Full Text] [Related]

  • 8. Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis.
    Goetghebeur D, Sarni D, Grossi Y, Leroyer C, Ghezzo H, Milic-Emiri J, Bellet M.
    Eur Respir J; 2002 Mar; 19(3):492-8. PubMed ID: 11936528
    [Abstract] [Full Text] [Related]

  • 9. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?
    Vilozni D, Lavie M, Sarouk I, Efrati O.
    Am J Respir Crit Care Med; 2012 Jul 01; 186(1):82-7. PubMed ID: 22538801
    [Abstract] [Full Text] [Related]

  • 10. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M, VanDevanter DR, Ren CL, Elkin EP, Pasta DJ, Konstan MW, Morgan WJ, Investigators of Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Pediatr Pulmonol; 2015 Sep 01; 50(9):856-62. PubMed ID: 26086901
    [Abstract] [Full Text] [Related]

  • 11. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.
    Davies J, Sheridan H, Bell N, Cunningham S, Davis SD, Elborn JS, Milla CE, Starner TD, Weiner DJ, Lee PS, Ratjen F.
    Lancet Respir Med; 2013 Oct 01; 1(8):630-638. PubMed ID: 24461666
    [Abstract] [Full Text] [Related]

  • 12. Analysis of tidal breathing profiles in cystic fibrosis and COPD.
    Colasanti RL, Morris MJ, Madgwick RG, Sutton L, Williams EM.
    Chest; 2004 Mar 01; 125(3):901-8. PubMed ID: 15006948
    [Abstract] [Full Text] [Related]

  • 13. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D, Piccorelli AV, Hannah WB, Dalrymple SN, Pace RG, Durie PR, Ling SC, Knowles MR, Stonebraker JR.
    PLoS One; 2018 Mar 01; 13(10):e0205257. PubMed ID: 30307979
    [Abstract] [Full Text] [Related]

  • 14. Peak inspiratory flows in children with cystic fibrosis.
    Gauld LM, Briggs K, Robinson P.
    J Paediatr Child Health; 2003 Apr 01; 39(3):210-3. PubMed ID: 12654145
    [Abstract] [Full Text] [Related]

  • 15. Spirometry use in children hospitalized with asthma.
    Tan CC, McDowell KM, Fenchel M, Szczesniak R, Kercsmar CM.
    Pediatr Pulmonol; 2014 May 01; 49(5):451-7. PubMed ID: 24000189
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cough characteristics and FVC maneuver in cystic fibrosis.
    Vilozni D, Lavie M, Ofek M, Sarouk I, Efrati O.
    Respir Care; 2014 Dec 01; 59(12):1912-7. PubMed ID: 25249647
    [Abstract] [Full Text] [Related]

  • 20. Lung function determinants and mortality of children and adolescents with cystic fibrosis in South Africa 2007-2016.
    Vandenbroucke NJ, Zampoli M, Morrow B.
    Pediatr Pulmonol; 2020 Jun 01; 55(6):1381-1387. PubMed ID: 32176840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.